Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
주식 순위 #30386
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
주가
$0.22227521
시가총액
$17.81M
변동 (1일)
0.00%
변동 (1년)
-14.81%
국가
TW
거래 TaiwanJ Pharmaceuticals Co., Ltd. (6549)

카테고리

TaiwanJ Pharmaceuticals Co., Ltd. (6549)의 주가 이력
최고 종가: $0.22 (2026-08-01 기준)

최저 종가: $1.48 (2015-10-01 기준)
TaiwanJ Pharmaceuticals Co., Ltd.의 주가 이력 (2015 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -0.02%
2025 -4.42%
2024 -46.55%
2023 39.35%
2022 -2.83%
2021 -22.13%
2020 32.12%
2019 63.58%
2018 -45.16%
2017 -41.89%
2016 -53.24%
2015 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.89 35.09%
US
$996.61 51.72%
NL
$114.98 -21.01%
AU
$735.86 6.07%
CH
$1.06K -5.95%
KR